These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 12414841

  • 1. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
    Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4872-8. PubMed ID: 12414841
    [Abstract] [Full Text] [Related]

  • 2. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.
    Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2664-72. PubMed ID: 10443657
    [Abstract] [Full Text] [Related]

  • 3. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 4. Adrenal incidentaloma: a new cause of the metabolic syndrome?
    Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R.
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [Abstract] [Full Text] [Related]

  • 6. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
    Giordano R, Picu A, Marinazzo E, D'Angelo V, Berardelli R, Karamouzis I, Forno D, Zinnà D, Maccario M, Ghigo E, Arvat E.
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Are body mass or insulin resistance independently associated with cardiovascular risk factors in non-diabetic elderly Nigerians?
    Ezenwaka CE, Akanji AO, Unwin N, Alberti KG.
    Diabet Med; 1996 Oct; 13(10):874-81. PubMed ID: 8911781
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors.
    Albiger N, Testa RM, Almoto B, Ferrari M, Bilora F, Petrobelli F, Pagnan A, Mantero F, Scaroni C.
    Horm Metab Res; 2006 Jun; 38(6):405-10. PubMed ID: 16823723
    [Abstract] [Full Text] [Related]

  • 12. Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas.
    Yener S, Ertilav S, Secil M, Akinci B, Demir T, Kebapcilar L, Yesil S.
    Med Princ Pract; 2012 Jun; 21(5):429-34. PubMed ID: 22398948
    [Abstract] [Full Text] [Related]

  • 13. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G, Vicennati V, Rinaldi E, Morselli-Labate AM, Giampalma E, Mosconi C, Pagotto U, Pasquali R.
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [Abstract] [Full Text] [Related]

  • 14. Low insulin sensitivity measured by both quantitative insulin sensitivity check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery.
    Rajala U, Laakso M, Päivänsalo M, Pelkonen O, Suramo I, Keinänen-Kiukaanniemi S.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5092-7. PubMed ID: 12414877
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study.
    Bonora E, Kiechl S, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M, Willeit J.
    Diabetologia; 2000 Feb; 43(2):156-64. PubMed ID: 10753036
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Sartorato P, Zulian E, Benedini S, Mariniello B, Schiavi F, Bilora F, Pozzan G, Greggio N, Pagnan A, Mantero F, Scaroni C.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1015-8. PubMed ID: 17200174
    [Abstract] [Full Text] [Related]

  • 19. Obesity indices and major components of metabolic syndrome in young adult Arab subjects.
    Al-Shayji IA, Akanji AO.
    Ann Nutr Metab; 2004 Mar; 48(1):1-7. PubMed ID: 14639040
    [Abstract] [Full Text] [Related]

  • 20. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM, Dowse GK, Zimmet PZ.
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.